Singular Genomics Systems Cash Flow Statement 2019-2024 | OMIC

Fifteen years of historical annual cash flow statements for Singular Genomics Systems (OMIC).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-94.82$-90.88$-98.77$-27.95$-12.32
$6.25$6.87$3.28$0.96$0.34
$17.17$13.73$46.70$1.26$0.17
$23.42$20.60$49.98$2.21$0.51
$0.35$-0.91$0$0$0
$-3.54$-13.49$0$0$0
$0.27$-1.17$1.85$-0.15$0.24
$-0.88$-1.33$-7.45$-0.13$-0.09
$-2.25$-16.82$-2.91$0.86$0.42
$-73.65$-87.09$-51.70$-24.87$-11.40
$-0.97$-6.02$-4.86$-1.38$-0.80
$0$0$0$0$0
$0$0$0$0$0
$14.78$-33.54$-126.00$25.39$-30.70
$0$0$0$0$0
$14.78$-33.54$-126.00$25.39$-30.70
$0$0$0$0$0
$13.81$-39.57$-130.86$24.01$-31.50
$0$0$131$7.50$2.46
$0$0$0$0$0
$0$0$131$7.50$2.46
$0.70$0.90$4.33$0.05$0.02
$0.70$0.90$242$0.02$44.84
$0$0$0$0$0
$0$0$0$0$0
$0.70$0.90$372$7.52$47.30
$-59.14$-125.76$190$6.65$4.41
$11.40$13.67$9.23$1.06$0.17
$0$0$0$0$0